Literature DB >> 2843497

Structure of the activated c-raf-1 gene from human stomach cancer.

K Shimizu1, Y Nakatsu, S Nomoto, M Sekiguchi.   

Abstract

We previously isolated a novel human transforming gene from a primary stomach cancer and identified it as an activated version of the c-raf-1 gene which is the human homologue of v-raf, a viral oncogene encoding a serine/threonine-specific protein kinase. Analyses of cDNA and genomic clones of this gene revealed that it was generated by substitution of 5'-sequence (exons 1-5) of the normal c-raf-1 gene with an unrelated human sequence. We identified the region in the genomic clone where the rearrangement had occurred. The rearranged EcoRI fragment was detected in all the primary transformants obtained from two independent transfections, suggesting that the recombination had occurred in the primary cancer. By sequence analysis of cDNA, the putative product of the transforming gene was inferred to have a hydrophobic stretch ahead of the ser/thr-protein kinase domain of the c-raf-1 gene product. We introduced one of the cDNA which contains the 1.6-kb open reading frame into the pUC9 vector. An autophosphorylating, 58 kd protein was induced in Escherichia coli cells bearing the plasmid upon induction. Since ser/thr-protein kinase activity of the normal c-raf protein has not been evidenced, these results suggest that the truncation/replacement of the amino-terminal domain of the c-raf-1 protein leads to constitutive activation of the protein kinase probably residing on the downstream domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2843497

Source DB:  PubMed          Journal:  Princess Takamatsu Symp


  2 in total

1.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.

Authors:  D T W Jones; S Kocialkowski; L Liu; D M Pearson; K Ichimura; V P Collins
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

2.  CRAF R391W is a melanoma driver oncogene.

Authors:  Mohammad Atefi; Bjoern Titz; Jennifer Tsoi; Earl Avramis; Allison Le; Charles Ng; Anastasia Lomova; Amanda Lassen; Michael Friedman; Bartosz Chmielowski; Antoni Ribas; Thomas G Graeber
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.